Results 281 to 290 of about 484,106 (362)

Evaluating inhaled corticosteroids' impact on osteoporosis and fracture risk in COPD patients: a real-world evidence-based systematic review and meta-analysis. [PDF]

Front Med (Lausanne)
Huang HF, Hsu CW, Hsieh FT, Liao KM.
europepmc   +1 more source

Effects of a 4‐week free‐sugar avoidance during periodontal therapy: An explorative randomized controlled clinical trial

Journal of Periodontology, EarlyView.
Abstract Background This study investigated the effect of a 4‐week free‐sugar avoidance on periodontal parameters during periodontal therapy. Methods Twenty‐one patients with untreated periodontitis and daily free‐sugar intake were allocated to a sugar avoidance group (SAG) and a control group (CG).
Christina L. Pappe, Beeke Peters, Olga Pivovarova‐Ramich, Robert Schremmer, Aysegül Adam, Kirstin Vach, Henrik Dommisch, Johan P. Woelber   +7 more
wiley   +1 more source

Antenatal corticosteroids for pregnant women at risk of preterm labour in low- and middle-income countries: utilisation and facility readiness. [PDF]

J Glob Health
Yang WC, Arsenault C, Fan VY, Leslie HH, Farooq F, Pembe AB, Getachew T, Smith ER.   +7 more
europepmc   +1 more source

Intestinal involvement in graft versus host disease in children: An overview by the ESPGHAN Gastroenterology Committee

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Graft versus host disease (GVHD) is a complication that frequently occurs after haematopoietic stem cell transplantation and concerns many children in paediatric haematology‐oncology and bone marrow transplantation departments. It can affect various organs, with the skin, gastrointestinal tract and liver being the most commonly involved.
Marina Vincent, Amit Assa, Osvaldo Borrelli, Matjaž Homan, Javier Martin‐de‐Carpi, Zrinjka Misak, Maria Giovanna Puoti, Isabelle Scheers, Sara Sila, Caterina Strisciuglio, Christos Tzivinikos, Jernej Dolinsek, Emmanuel Mas   +12 more
wiley   +1 more source

COVID-19-related organising pneumonia in patients with secondary antibody deficiency responds to immunoglobulin. [PDF]

ERJ Open Res
Moolji J, Leung WM, Richman-Eisenstat J, Adatia A.   +3 more
europepmc   +1 more source

Impaired physical fitness in pediatric inflammatory bowel disease

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objective There are only a few studies on physical fitness in pediatric inflammatory bowel disease (PIBD). We compared physical fitness in PIBD patients versus healthy controls and analyzed the role of contributing disease‐ and patient‐related factors.
Saija Kantanen, Kati Räsänen, Kaija‐Leena Kolho, Heini Huhtala, Kalle Sipilä, Ilkka Pörsti, Laura Vekara, Eija Piippo‐Savolainen, Timo Lakka, Pekka Arikoski, Pauliina Hiltunen   +10 more
wiley   +1 more source

Plasma Cell Balanitis Unresponsive to Topical Corticosteroids: Combined Efficacy of Tacrolimus and Emerging Evidence for Underrecognized Intrinsic Resistance to Corticosteroids. [PDF]

Cureus
Miyajima M, Oyama N, Inamura S, Imamura Y, Hasegawa M.   +4 more
europepmc   +1 more source

Cost‐utility analysis of sequential therapies for pediatric‐onset eosinophilic esophagitis

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Topical corticosteroids, proton‐pump inhibitors (PPI) and elimination diets (ED) are equally recommended as first‐line therapies for pediatric eosinophilic esophagitis (EoE). Dupilumab (DUP) is usually used for refractoriness. We aim to assess the cost‐utility of all potential sequential treatments for EoE.
José Vicente Arcos‐Machancoses, Elena Crehuá‐Gaudiza, Cecilia Martínez‐Costa   +2 more
wiley   +1 more source

Rectal budesonide: A potential game changer after Kasai hepatoportoenterostomy

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Intravenous or oral steroid administration in patients with biliary atresia (BA) after Kasai hepatoportoenterostomy (HPE) is commonly practiced, however, the benefits remain controversial. Some studies suggest no positive effects while risking steroid associated side effects.
Stefanie Langreen, Nathalie Pauer, Eva D. Pfister, Norman Junge, Ulrich Baumann, Omid Madadi‐Sanjani, Claus Petersen, Jens Dingemann, Nagoud Schukfeh   +8 more
wiley   +1 more source